Vanguard Personalized Indexing Management
ACAD icon

Vanguard Personalized Indexing Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$354K Buy
13,999
+1,734
+14% +$38.2K ﹤0.01% 1600
2026
Q1 		$273K Buy
12,265
+4,453
+57% +$106K ﹤0.01% 1660
2025
Q4 		$209K Buy
+7,812
New +$187K ﹤0.01% 1705
2025
Q2 		– Sell
-11,122
Closed -$185K – 1947
2025
Q1 		$185K Sell
11,122
-524
-4% -$9.52K ﹤0.01% 1534
2024
Q4 		$214K Buy
+11,646
New +$188K ﹤0.01% 1500

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Personalized Indexing Management's ACAD Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its Acadia Pharmaceuticals (ACAD) stake by 14% in Q2 2026, buying an estimated $38.2K and bringing the position to 13,999 shares worth $354K. The position accounts for ﹤0.01% of the portfolio, ranked #1600.

Vanguard Personalized Indexing Management first reported a position in ACAD in Q4 2024 and has held it in 5 quarters since. 352 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • Vanguard Personalized Indexing Management held 13,999 shares of Acadia Pharmaceuticals worth $354K as of Q2 2026.
  • Vanguard Personalized Indexing Management bought 1,734 Acadia Pharmaceuticals shares in Q2 2026, an estimated $38.2K.
  • Acadia Pharmaceuticals made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #1600 holding.
  • Vanguard Personalized Indexing Management first reported a position in Acadia Pharmaceuticals in Q4 2024 and has held it in 5 quarters since.
  • 352 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.